Marshall Wace, LLP Moderna, Inc. Call Options Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $3.71 Million - $5.02 Million	-31,300 Reduced 89.68%	3,600 $437,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $8.32 Million - $12.1 Million	-61,300 Reduced 63.72%	34,900 $5.36 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $3.43 Million - $6.09 Million	29,000 Added 43.15%	96,200 $17.3 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $2.2 Million - $3.61 Million	-18,600 Reduced 21.68%	67,200 $7.96 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $11.3 Million - $17.1 Million	-96,600 Reduced 52.96%	85,800 $12.3 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $23.1 Million - $42.9 Million	182,400 New	182,400 $31.4 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.